Know Labs, Inc. surged 1.25% in after-hours trading, following the company's announcement of its technology licensing platform KTL, which authorizes over 330 global patents for use in medical diagnostics, industrial processes, and automotive health monitoring. The company focuses on developing sensor technology based on radio frequency and microwave spectroscopy for non-invasive continuous glucose monitoring, with the device currently in the prototype stage and seeking FDA approval.
Comments
No comments yet